Shareholder of Exelixis (NASDAQ: EXEL) plans Rule 144 sale of 42,422 shares

Rhea-AI Filing Summary

A shareholder of Exelixis filed a notice to sell 42,422 shares of common stock under Rule 144. The shares are expected to be sold on or about 02/17/2026 through NASDAQ, with Morgan Stanley Smith Barney LLC listed as the broker.

These shares were acquired on 02/17/2026 through a stock option exercise from the issuer, paid for in cash, and have an indicated aggregate market value of $1,880,439.99. The filing notes that total shares outstanding are 259,708,689 for context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	42422	1880439.99	259708689	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Stock Option Exercise	Issuer			42422	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for EXEL disclose?

The Form 144 discloses that an Exelixis shareholder intends to sell 42,422 shares of common stock under Rule 144. The filing outlines share amount, market value, acquisition method, broker information, and timing of the planned sale through NASDAQ.

How many Exelixis (EXEL) shares are planned to be sold under this Form 144?

The shareholder plans to sell 42,422 shares of Exelixis common stock. The filing also reports an aggregate market value of about $1,880,439.99 for these shares, providing a sense of the transaction’s dollar size relative to the issuer’s equity.

When will the Exelixis (EXEL) shares be sold according to the Form 144?

The Form 144 lists an approximate sale date of 02/17/2026. This date reflects when the 42,422 shares of Exelixis common stock are expected to be sold on NASDAQ, subject to Rule 144 conditions and the shareholder’s execution of the transaction.

How were the Exelixis (EXEL) shares being sold under Form 144 acquired?

The shares were acquired on 02/17/2026 through a stock option exercise from the issuer. The Form 144 states the nature of payment was cash, meaning the holder exercised options for cash to obtain the 42,422 shares before the planned resale.

Which broker will handle the planned Exelixis (EXEL) share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction. The shares are to be sold on NASDAQ, with this broker’s New York office identified in the Form 144 as handling the sale process.

How many Exelixis (EXEL) shares are outstanding in this Form 144?

The Form 144 notes that 259,708,689 shares of Exelixis common stock are outstanding. This figure provides context for the planned sale of 42,422 shares, showing the relative size of the transaction versus the company’s total share count.